Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Business Exposures
< Previous 1 2
...
14 15 16 17 18 19 20 21 22
...
99 100 Next >
APLT Deadline to Lead in Securities Fraud Lawsuit is February 18, 2025 - Contact Kaplan Fox &amp; Kilsheimer LLP
Via TheNewswire.com
Topics Fraud Lawsuit
Exposures Financial Legal Product Safety
BioMedNewsBreaks — Clene Inc. (NASDAQ: CLNN) Secures $10 Million Debt Facility to Advance Neurodegenerative Disease Treatments
Via Investor Brand Network
Exposures Product Safety
Tickers CLNN
IBD 50's Hims & Hers Tumbles After FDA Pulls Lilly's Weight-Loss Drug From Shortage List
Via Investor's Business Daily
Exposures Product Safety
Tickers HIMS LLY NVO
Salignostics Secures TGA Approval for Saliva-Based Home Pregnancy Test
Via News Direct
Exposures Product Safety
Envoy Medical Names Seven Investigational Sites for Participation in Its Pivotal Clinical Study
Via Newsfile
Exposures Product Safety
Tickers ASX:COH COCH
EXCLUSIVE: MIRA Pharmaceuticals Files FDA Application To Start Human Trials For Its Lead Pain Treatment
Via Benzinga
Exposures Product Safety
Tickers MIRA
Mesoblast's Cell Therapy Treatment For Graft Versus Host Disease Gets FDA Approval, Stock Surges
Via Benzinga
Exposures Product Safety
Tickers ASX:MSB MESO
Jeffrey Allan Parsons Champions the Value of Family and Legacy in Estate Sales
Via Zexprwire
Topics Product Recall
Exposures Legal Product Safety
Dark. Cinematic. Danceable. Jaylious Takes Electronic Dance Music to New Depths
Via AB Newswire
Topics Product Recall
Exposures Legal Product Safety
Deadline to Lead in Securities Fraud Lawsuit Against Applied Therapeutics, Inc. (APLT) is February 18, 2025 - Contact Kaplan Fox & Kilsheimer LLP
Via NewMediaWire
Topics Fraud Lawsuit
Exposures Financial Legal Product Safety
Deadline to Lead in Securities Fraud Lawsuit Against Applied Therapeutics, Inc. (APLT) is February 18, 2025 - Contact Kaplan Fox &amp; Kilsheimer LLP
Via TheNewswire.com
Topics Fraud Lawsuit
Exposures Financial Legal Product Safety
Tonix Pharma Stock’s Retail Chatter Explodes After FDA Nod For New Drug Application
Via Stocktwits
Exposures Product Safety
Kaplan Fox & Kilsheimer LLP Alerts Investors to a Securities Class Action Against Applied Therapeutics, Inc. (APLT) Lead Plaintiff Deadline is February 18, 2025
Via NewMediaWire
Exposures Product Safety
Kaplan Fox &amp; Kilsheimer LLP Alerts Investors to a Securities Class Action Against Applied Therapeutics, Inc. (APLT) Lead Plaintiff Deadline is February 18, 2025
Via TheNewswire.com
Exposures Product Safety
Merck Discontinues Certain Cancer Candidate Trials After Futility Analysis
Via Benzinga
Exposures Product Safety
Tickers MRK
Colorectal Surgery Leader Dr. I. Emre Gorgun Joins Actuated Medical's Medical Advisory Board
Via PRLog
Topics Intellectual Property
Exposures Intellectual Property Product Safety
Regeneron's Best-Selling Eye Drug Eylea's Higher Dose Formulation Meets Primary Goal In Another Form Of Retinal Disease Study
Via Benzinga
Exposures Product Safety
Tickers BAYRY REGN
FDA Rejects Johnson & Johnson's Injectable Version Of Approved Drug For Lung Cancer
Via Benzinga
Exposures Product Safety
Tickers AZN JNJ
Salignostics Secures TGA Approval for Saliva-Based Home Pregnancy Test
Via News Direct
Exposures Product Safety
US Marijuana Research is Witnessing an Evolving Landscape
Via Investor Brand Network
Topics Cannabis
Exposures Cannabis Product Safety
US Marijuana Research is Witnessing an Evolving Landscape
Via CannabisNewsWire
Topics Cannabis
Exposures Cannabis Product Safety
Tickers CURLF
The Next Wave of Health AI: Analysts Highlight Breakthroughs in Clinical Trials and Patient Care
Via FinancialNewsMedia
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
Tickers AVAI BTAI HWAIF ICAD
InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Advances Non-Opioid Fibromyalgia Treatment with FDA NDA Acceptance
Via Investor Brand Network
Exposures Product Safety
Tickers TNXP
STEMart Announces Balloon Catheter Testing Services to Ensure Medical Device Safety and Regulatory Compliance
Via AB Newswire
Topics Economy
Exposures Interest Rates Product Safety
New Approaches to Psychedelic Clinical Trials Could Overcome Regulatory Hurdles
Via Investor Brand Network
Exposures Product Safety
Palm-Sized Innovation: How Microbot Medical Is Helping Redefine Surgical Robotics
Via News Direct
Exposures Product Safety
Tickers MBOT
FDA Approves Checkpoint Therapeutics' Skin Cancer Drug One Year After Rejection
Via Benzinga
Exposures Product Safety
Tickers CKPT
Neurocrine's Drug Gains FDA Nod As First Targeted Treatment For Certain Type Of Inherited Disorder, Analyst Highlights Blockbuster Potential
Via Benzinga
Exposures Product Safety
Tickers CRNX NBIX
BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Secures FDA Clearance for Innovative Arrhythmia Assessment Device
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property Product Safety
Tickers BEAT
Neurocrine Wins FDA Approval For Genetic Disorder Drug
Via Investor's Business Daily
Exposures Product Safety
Tickers ABBV NBIX
< Previous 1 2
...
14 15 16 17 18 19 20 21 22
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.